We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Review |

West Nile Virus: Review of the Literature

Lyle R. Petersen, MD, MPH1; Aaron C. Brault, PhD1; Roger S. Nasci, PhD1
[+] Author Affiliations
1Division of Vector-Borne Diseases, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, US Public Health Service, Department of Health and Human Services, Fort Collins, Colorado
JAMA. 2013;310(3):308-315. doi:10.1001/jama.2013.8042.
Text Size: A A A
Published online

Importance  Since its introduction in North America in 1999, West Nile virus has produced the 3 largest arboviral neuroinvasive disease outbreaks ever recorded in the United States.

Objective  To review the ecology, virology, epidemiology, clinical characteristics, diagnosis, prevention, and control of West Nile virus, with an emphasis on North America.

Evidence Review  PubMed electronic database was searched through February 5, 2013. United States national surveillance data were gathered from the Centers for Disease Control and Prevention.

Findings  West Nile virus is now endemic throughout the contiguous United States, with 16 196 human neuroinvasive disease cases and 1549 deaths reported since 1999. More than 780 000 illnesses have likely occurred. To date, incidence is highest in the Midwest from mid-July to early September. West Nile fever develops in approximately 25% of those infected, varies greatly in clinical severity, and symptoms may be prolonged. Neuroinvasive disease (meningitis, encephalitis, acute flaccid paralysis) develops in less than 1% but carries a fatality rate of approximately 10%. Encephalitis has a highly variable clinical course but often is associated with considerable long-term morbidity. Approximately two-thirds of those with paralysis remain with significant weakness in affected limbs. Diagnosis usually rests on detection of IgM antibody in serum or cerebrospinal fluid. Treatment is supportive; no licensed human vaccine exists. Prevention uses an integrated pest management approach, which focuses on surveillance, elimination of mosquito breeding sites, and larval and adult mosquito management using pesticides to keep mosquito populations low. During outbreaks or impending outbreaks, emphasis shifts to aggressive adult mosquito control to reduce the abundance of infected, biting mosquitoes. Pesticide exposure and adverse human health events following adult mosquito control operations for West Nile virus appear negligible.

Conclusions and Relevance  In North America, West Nile virus has and will remain a formidable clinical and public health problem for years to come.

Figures in this Article

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?


Place holder to copy figure label and caption
Figure 1.
Schematic of Pathogenesis of West Nile Virus Infection

Following the bite of an infected mosquito, infection begins in keratinocytes and immune cells in the epidermis and spreads to draining lymph nodes. Viremia originating in the lymph nodes disseminates infection to peripheral organs.

Graphic Jump Location
Place holder to copy figure label and caption
Figure 2.
West Nile Virus Neuroinvasive Mechanisms

Potential mechanisms for neuroinvasion of West Nile virus includ (1) direct infection of the vascular endothelium and subsequent entry to the central nervous system, (2) viral passage through the vascular endothelium due to disruption of the blood-brain barrier integrity by vasoactive cytokines, (3) a Trojan horse mechanism through which infected monocytes are trafficked into the central nervous system, or (4) retrograde axonal transport to the central nervous system following infection of peripheral neurons.

Graphic Jump Location
Place holder to copy figure label and caption
Figure 3.
Map of Average Annual Human Neuroinvasive Disease Incidence in the United States, 1999-2012
Graphic Jump Location
Place holder to copy figure label and caption
Figure 4.
Cumulative Number of Human West Nile Virus Neuroinvasive Disease Cases by Week of Onset, 1999-2012
Graphic Jump Location




You need to register in order to view this quiz.


Some tools below are only available to our subscribers or users with an online account.

84 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Articles Related By Topic
Related Collections
PubMed Articles